Page last updated: 2024-09-04

(e)-3-(4-t-butylphenyl)-n-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide and oxazoles

(e)-3-(4-t-butylphenyl)-n-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide has been researched along with oxazoles in 1 studies

Compound Research Comparison

Studies
((e)-3-(4-t-butylphenyl)-n-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide)
Trials
((e)-3-(4-t-butylphenyl)-n-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide)
Recent Studies (post-2010)
((e)-3-(4-t-butylphenyl)-n-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide)
Studies
(oxazoles)
Trials
(oxazoles)
Recent Studies (post-2010) (oxazoles)
850659,2813662,561

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ohshima, Y; Suzuki-Karasaki, M; Suzuki-Karasaki, Y; Takata, N; Tokuhashi, Y; Yoshida, Y1

Other Studies

1 other study(ies) available for (e)-3-(4-t-butylphenyl)-n-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide and oxazoles

ArticleYear
Mitochondrial Ca2+ removal amplifies TRAIL cytotoxicity toward apoptosis-resistant tumor cells via promotion of multiple cell death modalities.
    International journal of oncology, 2017, Volume: 51, Issue:1

    Topics: Acrylamides; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzoates; Biological Transport; Bone Neoplasms; Bridged Bicyclo Compounds, Heterocyclic; Calcium; Cell Membrane Permeability; Cell Proliferation; Drug Resistance, Neoplasm; Humans; Melanoma; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Osteosarcoma; Oxazoles; TNF-Related Apoptosis-Inducing Ligand; Tumor Cells, Cultured

2017